Press releases - Ypsomed

Ypsomed expands to more countries

05/10/2017 - 7:00am Press Releases Ypsomed Group

Burgdorf – Ypsomed invests into new subsidiaries to allow even more people with diabetes to benefit from the advantages of insulin pump therapy.

Ypsomed’s reusable YpsoPen introduced in Malaysia by Biocon

04/12/2017 - 7:00am Press Releases Ypsomed Group

Burgdorf – Ypsomed has collaborated with Biocon, an emerging global biopharmaceutical company headquartered in India, to customise its reusable YpsoPen for use with Biocon’s insulin cartridges. This customised reusable pen will be marketed by Biocon as INSUPen Pro™ in Malaysia.

Ypsomed opens a new production line in Solothurn

01/25/2017 - 7:00am Press Releases Ypsomed Group

Burgdorf – Following 18 months of industrialisation, Ypsomed opened its new production line in their Solothurn works and will have created over 50 new jobs on final expansion. The inauguration was held yesterday with representatives of local commerce and guests from politics in attendance.

Ypsomed honoured as successful company with future-oriented work models

01/12/2017 - 7:00am Press Releases Ypsomed Group

Burgdorf – On 11 January 2017, Ypsomed was honoured with the 20th Solothurn Business Award. Ypsomed received an award for their outstanding business performance in the canton of Solothurn in terms of implementing modern work models and for its commitment to promoting the production location in Switzerland. The ceremony was held in front of over 350 attendees representing commerce, politics and administration.

Ypsomed gains a further customer in Russia

12/20/2016 - 7:00am Press Releases Ypsomed Group

Burgdorf – The human insulin of Russian pharmaceutical company GEROPHARM will in future be administered with a pen from Ypsomed's ServoPen® platform. This is a further confirmation of Ypsomed's platform strategy in the field of injection systems.